Author/Authors :
Mehrpour، Masoud نويسنده Firoozgar Clinical Research Development Center (FCRDC), Neurology Department, Tehran University of Medical Sciences, Tehran, Iran , , Motamed، Mohammad Reza نويسنده MD, Assistant professor of neurology, Department of Neurology, Firoozgar Hospital , , Aghaei، Mahboubeh نويسنده MD, Resident of neurology, Department of Neurology, Firoozgar Hospital , , Badi، Zahra نويسنده Research Center for Traditional Medicine and History of Medicine AND Department of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran Badi, Zahra
Abstract :
Stroke is an important cause of disability and death worldwide, with the majority of strokes occurring in older people. Thrombolysis with recombinant tissue plasminogen activator (r-TPA) is the approved treatment for acute ischemic stroke. A major concern of physicians, who treat acute ischemic stroke with recombinant tissue plasminogen activator (r-TPA,) is the risk of intracerebral hemorrhage. However, other adverse reactions, including anaphylaxis and angioedema, can also occur. Here we report an interesting soft tissue reaction to intravenous r-TPA in an 80 year-old male who was treated for acute ischemic stroke.
